PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales and Scotland, PrEP is available through NHS sexual health clinics.It is also...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Queen’s University Announces Novel Drug Delivery System With Potential to Reduce HIV Rates

    Queen’s, along with their collaborators, PATH, ViiV Healthcare, the Population Council and LTS Lohmann Therapie-Systeme AG will combine their complementary expertise to develop a novel microarray patch for HIV PrEP in preparation for future clinical trials.

    16 February 2018 | Infection Control Today
  • New York Will Investigate Reports of Gay Men Denied Insurance

    State financial regulators in New York said Wednesday that they would investigate reports that gay men have been denied insurance policies covering life, disability or long-term care because they were taking medication to protect themselves against H.I.V. Such denials would amount to illegal discrimination based on sexual orientation, and the companies doing so could be penalized, said Maria T. Vullo, the state’s superintendent of financial services.

    15 February 2018 | New York Times
  • Prescribing PrEP? Don't Wait for Patients to Ask

    In the clinic, providers must initiate conversation with people who may benefit from PrEP. Provider-initiated conversations about PrEP resulted in a greater proportion of their eligible caseload receiving PrEP. It was especially effective in increasing the number of underrepresented or underreported patients (eg. women, heterosexual adults, transgender adults, people engaged in sex work, and injection drug users) receiving PrEP.

    14 February 2018 | Contemporary Clinic
  • He Took a Drug to Prevent AIDS. Then He Couldn't Get Disability Insurance

    When Dr. Cheng applied for disability insurance — which many young doctors do to protect a lifetime’s worth of income should they be hurt — he was told that, because he was taking Truvada, he could have only a five-year policy.

    12 February 2018 | New York Times
  • Are We Really Prepared To Stop HIV?

    Last weekend (9/10 February) in Amsterdam, European healthcare workers, activists, advocates and policy makers were at a conference discussing how they could facilitate HIV pre-exposure prophylaxis (PrEP) more widely across European countries. Is it right to continue to limit or stagger access to PrEP to those at highest need in England when it is available freely on the NHS in Scotland and Wales?

    12 February 2018 | Huffington Post
  • New Campaign Seeks To Lower Hiv Transmission Rate For Black Men

    The San Francisco Department of Public Health launched a new campaign today aimed at reducing the spread of HIV among black men through the use of a daily pill that can be 90 percent effective in preventing transmission of the disease.

    12 February 2018 | SFGate
  • PrEP Shop: Daily PrEP for only £55 a month

    We’ve created PrEP Shop to make it easier for you to buy generic HIV PrEP from someone you trust. By using the buying power of the NHS we aim to keep prices as affordable as we can.

    12 February 2018 | 56 Dean Street
  • PrEP in England

    Report on the Today programme, 46 minutes in.

    09 February 2018 | BBC Radio 4 (audio)
  • As PrEP Use Soars Among Men in California, Racial Disparities Persist

    Additionally, despite their high HIV rate, young men are much less likely to be on PrEP than their older peers.

    09 February 2018 | Poz
  • Australia: Breakthrough drug PrEP to be approved for public subsidy

    Hopes are high particularly in the gay community that the Pharmaceutical Benefits Advisory Committee will on Friday issue a long-awaited "positive recommendation" for Truvada, commonly known as PrEP.

    07 February 2018 | The Sydney Morning Herald
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.